5248

524412

AAREYDRUGS

img img img img
No Data Available

AAREY DRUGS & PHARM LTD Share Price Update

As of the latest trading session, AAREY DRUGS & PHARM LTD is trading at ₹77.5, down by ₹-2.23 or -2.79% from its previous close. The stock has moved between ₹76.30 and ₹80.00 today. Over the past year, the stock has delivered a return of 44.55%. In the last month, it has returned -13.83%.

AAREY DRUGS & PHARM LTD performance

Today’s low Today’s high
₹ 76.30 ₹ 80.00
₹ 77.99
52 week low 52 week high
₹ 47.76 ₹ 100.00
₹ 77.99
Open Price ₹ 79.73
Prev. Close ₹ 79.73
Volume (Shares) 7140.00
Total traded value ₹ 5.56
Upper Circuit ₹ 83.71
Lower Circuit ₹ 75.75
info

Investment Returns

Over 1 Month -13.83% Over 3 Months 11.94% Over 6 Months -9.02% Over 1 Year 44.55%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AAREY DRUGS & PHARM LTD fundamentals


  • Market cap (Cr) 221.10
  • P/E Ratio (TTM) 63.43
  • Beta 1.62
  • Book Value / share 51.13
  • Return on equity 2.96%
  • EPS (TTM) 1.21
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.57
info icon alternate text
  • Market cap (Cr) 217.60
  • P/E Ratio (TTM) 63.43
  • Beta 1.62
  • Book Value / share 51.13
  • Return on equity 2.96%
  • EPS (TTM) 1.21
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.57
info icon alternate text

AAREY DRUGS & PHARM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 189.47
Operating Expense 187.76
Net Profit 1.56
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.55
EBITDA 3.91
Effective Tax Rate (%) -21.87
Particulars DEC 2025 (Values in Cr)
Revenue 96.43
Operating Expense 99.69
Net Profit 0.57
Net Profit Margin (%) 0.59
Earnings Per Share (EPS) 0.20
EBITDA 2.67
Effective Tax Rate (%) 38.04
Particulars SEP 2025 (Values in Cr)
Revenue 84.16
Operating Expense 83.47
Net Profit 1.02
Net Profit Margin (%) 1.21
Earnings Per Share (EPS) 0.36
EBITDA 3.43
Effective Tax Rate (%) 31.08
Particulars JUN 2025 (Values in Cr)
Revenue 102.21
Operating Expense 102.03
Net Profit 1.37
Net Profit Margin (%) 1.34
Earnings Per Share (EPS) 0.48
EBITDA 3.26
Effective Tax Rate (%) 20.80
Particulars MAR 2025 (Values in Cr)
Revenue 108.10
Operating Expense 114.00
Net Profit 0.47
Net Profit Margin (%) 0.43
Earnings Per Share (EPS) 0.17
EBITDA 3.34
Effective Tax Rate (%) 70.55
Particulars MAR 2026 (Values in Cr)
Revenue 472.27
Operating Expense 472.95
Net Profit 3.97
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 1.39
EBITDA 13.26
Effective Tax Rate (%) 26.80
Particulars MAR 2025 (Values in Cr)
Revenue 473.94
Operating Expense 477.65
Net Profit 4.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 1.43
EBITDA 12.70
Effective Tax Rate (%) 34.09
Particulars MAR 2024 (Values in Cr)
Revenue 395.62
Operating Expense 397.24
Net Profit 4.68
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 1.84
EBITDA 11.42
Effective Tax Rate (%) 12.35
Particulars MAR 2023 (Values in Cr)
Revenue 418.96
Operating Expense 415.67
Net Profit 3.78
Net Profit Margin (%) 0.90
Earnings Per Share (EPS) 1.49
EBITDA 10.46
Effective Tax Rate (%) 37.20
Particulars MAR 2022 (Values in Cr)
Revenue 492.68
Operating Expense 485.40
Net Profit 6.54
Net Profit Margin (%) 1.32
Earnings Per Share (EPS) 2.72
EBITDA 14.02
Effective Tax Rate (%) 34.69
Particulars MAR 2025 (Values in Cr)
Book Value / Share 46.90
ROE % 2.96
ROCE % 6.38
Total Debt to Total Equity 0.24
EBITDA Margin 2.68
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.57
ROE % 3.74
ROCE % 6.09
Total Debt to Total Equity 0.28
EBITDA Margin 2.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.43
ROE % 3.26
ROCE % 6.28
Total Debt to Total Equity 0.22
EBITDA Margin 2.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.85
ROE % 6.16
ROCE % 9.79
Total Debt to Total Equity 0.15
EBITDA Margin 2.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.29
ROE % 6.81
ROCE % 9.38
Total Debt to Total Equity 0.19
EBITDA Margin 3.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.47
Total Assets 290.59
Total Liabilities 290.59
Total Equity 138.48
Share Outstanding 2
Price to Book Ratio 0.72
Return on Assets (%) 1.38
Return on Capital (%) 2.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.59
Total Assets 303.29
Total Liabilities 303.29
Total Equity 132.77
Share Outstanding 2
Price to Book Ratio 0.98
Return on Assets (%) 1.54
Return on Capital (%) 2.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 291.32
Total Liabilities 291.32
Total Equity 117.40
Share Outstanding 2
Price to Book Ratio 0.53
Return on Assets (%) 1.29
Return on Capital (%) 2.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 245.16
Total Liabilities 245.16
Total Equity 113.63
Share Outstanding 2
Price to Book Ratio 0.94
Return on Assets (%) 2.67
Return on Capital (%) 5.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 233.03
Total Liabilities 233.03
Total Equity 98.86
Share Outstanding 2
Price to Book Ratio 0.56
Return on Assets (%) 2.79
Return on Capital (%) 5.57
Particulars MAR 2025 (Values in Cr)
Net Income 6.10
Cash from Operations 12.20
Cash from Investing -5.93
Cash from Financing -4.48
Net change in Cash -0.12
Free Cash Flow 17.41
Particulars MAR 2024 (Values in Cr)
Net Income 5.34
Cash from Operations -1.66
Cash from Investing -1.70
Cash from Financing 5.58
Net change in Cash 0.88
Free Cash Flow -0.94
Particulars MAR 2023 (Values in Cr)
Net Income 6.00
Cash from Operations 0.99
Cash from Investing 0.44
Cash from Financing 1.35
Net change in Cash 0.51
Free Cash Flow 2.04
Particulars MAR 2022 (Values in Cr)
Net Income 10.02
Cash from Operations 4.08
Cash from Investing -3.21
Cash from Financing 2.25
Net change in Cash -0.45
Free Cash Flow 6.29
Particulars MAR 2021 (Values in Cr)
Net Income 8.30
Cash from Operations 7.14
Cash from Investing -2.87
Cash from Financing -2.45
Net change in Cash 0.14
Free Cash Flow 10.02
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 14.75 1.72 273.50 23.12 40.00
BLISS GVS PHARMA LTD. 424.80 34.37 3.76 4493.92 118.35 437.40
CIPLA LTD. 1398.50 27.69 3.28 112970.91 1165.55 1672.20
FERMENTA BIOTECH LTD. 295.20 13.02 2.13 868.80 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2208.70 36.65 16.50 37416.71 2194.15 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 24.96 4.59 273.50 23.12 40.00
AMRUTAJAN HEALTH LTD 559.55 25.08 4.36 1617.69 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8671.45 113.25 24.83 21678.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 424.80 45.68 3.89 4493.92 118.35 437.40

AAREY DRUGS & PHARM LTD shareholding pattern

Holding
56.49%
37.71%
4.17%
1.62%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

AAREY DRUGS & PHARM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
77.99 -2.18 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 80.40
  • 26 Days 83.40
  • 10 Days 82.60
  • 50 Days 80.40
  • 12 Days 83.10
  • 100 Days 76.90
  • 20 Days 83.80
  • 200 Days 73.60
79.26 PIVOT
First Support 77.03 First Resistance 81.95 Second Support 74.34 Second Resistance 84.18 Third Support 72.11 Third Resistance 86.87
RSI 39.65 ADX 27.01 MACD -0.25 Williams % R -89.57 Commodity Channel Index (CCI) -154.53
Date 2026-04-29 Week 159427.00 Same Day 134098.00 Month 131502.00
1 Year 1.63 3 Year 1.06
Over 1 Month
-13.83% down
Over 1 Year
44.55% down
Over 3 Months
11.94% down
Over 3 Years
39.38% down
Over 6 Months
-9.02% down
Over 5 Years
12.46% down

AAREY DRUGS & PHARM LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
Ex-Date Ex-Bonus Ratio
26 Jun 2012 25 Jun 2012 1:5
Dividend date Dividend amount Dividend type Record date Instrument type
13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
Ex-Date Ex-Bonus Ratio
26 Jun 2012 25 Jun 2012 1:5

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

Aarey Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 77.50 & for BSE ₹ 76.75 as on May 29 2026 03:29 PM.

What is the Market Cap of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Aarey Drugs & Pharmaceuticals Ltd for NSE ₹ 221.10 & for BSE ₹ 0.00 as on May 29 2026 03:29 PM.

What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 100.00 and ₹ 47.76 and for BSE is ₹ 100.00 and ₹ 49.01.

What is 1 year return for Aarey Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 44.55%.

What is the P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on May 29 2026 03:29 PM the price-to-earnings (PE) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 63.43.

What is the PB ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on May 29 2026 03:29 PM, the price-to-book (PB) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 51.13.

How to Buy Aarey Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Aarey Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarey Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarey Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarey Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|